Xiaoshuang Niu

机构：Zhengzhou University

发表论文 15 篇 · 总被引 300 次 · h-index 9

代表论文

• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 80)
• Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy (2023 · Journal of Controlled Release · 被引 35)
• Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy (2023 · Science China Life Sciences · 被引 35)
• Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy (2023 · Acta Pharmaceutica Sinica B · 被引 31)
• Discovery of a novel small molecule as CD47/SIRPα and PD-1/PD-L1 dual inhibitor for cancer immunotherapy (2024 · Cell Communication and Signaling · 被引 27)
• Peptide drugs: a new direction in cancer immunotherapy (2023 · Cancer Biology and Medicine · 被引 26)